Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ustekinumab Plus UVB-311nm Half-side Phototherapy in Patients With Psoriasis

NCT00870285 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT00870285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00870285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ustekinumab Plus UVB-311nm Half-side Phototherapy in Patients With Psoriasis
Lead sponsor
Medical University of Graz
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2009
Completion date
April 30, 2011
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis